96207-23-7

Upstream product

• 887406-96-4 4-(1-Methyl-cyclohexylmethoxy)-phenylamine 
• 85003-07-2 methyl 2-chloro-3-<4-(1-methylcyclohexylmethoxy)phenyl>propionate 
• 196079-42-2 Δ2CG 
• 64-17-5 ethanol 
• 85010-76-0 methyl (+)-3-<4-(1-methylcyclohexylmethoxy)phenyl>-(2S)-2-thiocyanatopropionate 
• 96207-24-8 (-)-(5S)-<4-(1-methylcyclohexylmethoxy)benzyl>-2,4-thiazolidinedione 1-phenylethylamine salt 
• 96206-78-9 2-Chloro-3-[4-(1-methyl-cyclohexylmethoxy)-phenyl]-propionic acid 
• 96206-80-3 methyl (-)-(2R)-2-chloro-3-<4-(1-methylcyclohexylmethoxy)phenyl>propionate 
• 14064-13-2 (1-methylcyclohexyl)methanol 
• 85002-76-2 4-(1-methylcyclohexylmethoxy)nitrobenzene 
• 100-00-5 4-chlorobenzonitrile 
• 17356-08-0 thiourea 
• 85010-78-2 2-bromo-3-<4-(1-methylcyclohexylmethoxy)phenyl>propionitrile 
• 85010-66-8 2-imino-5-<4-(1-methylcyclohexylmethoxy)benzyl>thiazolidin-4-one 

Downstream Products

• 96207-26-0 (+)-(5R)-<4-(1-methylcyclohexylmethoxy)benzyl>-2,4-thiazolidinedione 1-phenylethylamine salt 
• 96207-24-8 (-)-(5S)-<4-(1-methylcyclohexylmethoxy)benzyl>-2,4-thiazolidinedione 1-phenylethylamine salt 
• 96207-27-1 (+/-)-3-methyl-5-<4-(1-methylcyclohexylmethoxy)benzyl>-2,4-thiazolidinedione 

Relevant academic research and scientific papers

NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF

The present invention relates to novel thiazolidinedione derivatives expressed by the following formula (I) and the uses thereof. More specifically, the present invention relates to novel thiazolidinedione derivatives expressed by the following formula (I) and a pharmaceutical composition comprising the same. The novel thiazolidinedione derivatives of formula (I) according to the present invention can be effectively used for the prevention or treatment of cardiovascular disease, gastrointestinal disease and renal disease by inhibiting the activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) that decomposes prostaglandins as well as useful for the prevention of hair loss and the stimulation of hair growth, and osteogenic stimulation and wound healing.

Thiazolidine derivatives

Thiazolidine derivatives of the general formula: STR1 [wherein R1 is alkyl, cycloalkyl, phenylalkyl, phenyl, a five- or six-membered heterocyclic group including one or two hetero-atoms selected from the group consisting of nitrogen, oxygen and sulfur or a group of the formula STR2 (where R3 and R4 are the same or different and each is lower alkyl or R3 and R4 are combined to each other either directly or as interrupted by a hetero-atom selected from the group consisting of nitrogen, oxygen and sulfur to form a five- or six-membered ring); R2 means a bond or a lower alkylene group; L1 and L2 are the same or different and each is lower alkyl or L1 and L2 are combined to form an alkylene group, provided that when R1 is other than alkyl, L1 and L2 may further be hydrogen, respectively] are novel compounds and useful as, for example, remedies for diabetes, hyperlipemia and so on of mammals including human beings.